Suppr超能文献

[复发性前列腺癌的挽救性根治性前列腺切除术。发病率、肿瘤学及功能结果]

[Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results].

作者信息

Vidmar R, Marcq G, Flamand V, Fantoni J-C, Hénon F, Villers A, Ouzzane A

机构信息

Service d'urologie, hôpital Claude-Huriez, CHRU de Lille, rue Michel-Polonovski, 59000 Lille, France.

Service d'urologie, hôpital Claude-Huriez, CHRU de Lille, rue Michel-Polonovski, 59000 Lille, France.

出版信息

Prog Urol. 2017 Jun-Jul;27(8-9):458-466. doi: 10.1016/j.purol.2017.05.005. Epub 2017 May 31.

Abstract

INTRODUCTION

Salvage radical prostatectomy (sRP) for radiorecurrent prostate cancer (PCa) is a challenging procedure. To report our experience with sRP for selected patients with local recurrence after primary treatment for localised PCa.

METHODS

From 2005 to 2015, 24 patients underwent sRP for recurrent PCa in our center and were included in this retrospective study. Local recurrence was suspected by PSA increase>nadir+2ng/mL and was confirmed by biopsy. Perioperative complications according to Clavien-Dindo classification, oncological and functional results were analysed.

RESULTS

Overall, 24 patients with a median age of 59 years (IQR: 55-60) were included. Median follow-up was 25 months (IQR: 9-26). Procedures were performed with open-retropubic approach in 50 % and robot-assisted laparoscopic approach in 50 %. Overall, 5 (21 %) and 2 (8 %) patients experienced grade≤IIIa and grade≥IIIb postoperative complication, respectively. Surgical margins were positive in 46 % of cases. Three out of 4 patients with postoperatively detectable PSA (>0.2ng/mL) had positive surgical margins. Seven patients experienced biochemical recurrence in a median delay of 19 months (9-62). Seventy-one percent (5) of these patients experienced clinical recurrence in a median delay of 24 months (10-113). Severe urinary incontinence (≥3 pads/day) and erectile dysfunction were reported in 25 % and 63 %, respectively.

CONCLUSION

sRP for patients is a feasible procedure with encouraging local control rate and acceptable morbidity. This technique should be discussed as a treatment option for locally recurrent PCa in well-selected patients.

LEVEL OF EVIDENCE

摘要

引言

挽救性根治性前列腺切除术(sRP)用于治疗放射性复发的前列腺癌(PCa)是一项具有挑战性的手术。报告我们对局部前列腺癌初次治疗后局部复发的特定患者进行sRP的经验。

方法

2005年至2015年,我们中心有24例患者因复发性PCa接受了sRP,并纳入了这项回顾性研究。通过前列腺特异性抗原(PSA)升高>最低点+2 ng/mL怀疑局部复发,并通过活检确诊。根据Clavien-Dindo分类分析围手术期并发症、肿瘤学和功能结果。

结果

总体而言,纳入了24例患者,中位年龄为59岁(四分位间距:55-60岁)。中位随访时间为25个月(四分位间距:9-26个月)。50%的手术采用耻骨后开放入路,50%采用机器人辅助腹腔镜入路。总体而言,分别有5例(21%)和2例(8%)患者发生≤IIIa级和≥IIIb级术后并发症。46%的病例手术切缘阳性。4例术后可检测到PSA(>0.2 ng/mL)的患者中有3例手术切缘阳性。7例患者发生生化复发,中位延迟时间为19个月(9-62个月)。其中71%(5例)的患者发生临床复发,中位延迟时间为24个月(10-113个月)。严重尿失禁(≥3片/天)和勃起功能障碍的报告率分别为25%和63%。

结论

sRP对患者来说是一种可行的手术,局部控制率令人鼓舞,发病率可接受。对于精心挑选的局部复发PCa患者,应将该技术作为一种治疗选择进行讨论。

证据级别

4级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验